Adtalem Global Education Announces New $150 Million Share Repurchase Program
MWN-AI** Summary
Adtalem Global Education Inc. (NYSE: ATGE), a prominent healthcare educator in the United States, has announced a new share repurchase program allowing for the buyback of up to $150 million of its common stock through May 2028. This decision was made after the successful completion of a previous $300 million share repurchase program authorized in January 2024, which concluded ahead of schedule, indicating strong confidence in the company’s financial health and strategic direction.
The rapid completion of the prior repurchase program underscores Adtalem’s robust fundamentals and adherence to its “Growth with Purpose” strategy. CEO Steve Beard highlighted that market conditions have presented favorable opportunities for share repurchases at appealing valuations, which in turn enhances shareholder value. He emphasized a disciplined capital allocation approach aimed at fostering accelerated growth and expanding educational offerings in high-demand healthcare sectors.
Since February 2022, Adtalem has significantly returned $763 million to shareholders, reducing the number of shares outstanding by 28% at an average repurchase price of around $49, demonstrating its commitment to shareholder returns. Currently, approximately 36 million shares remain outstanding.
The new share repurchase program will allow management to determine the timing and amount of purchases based on market conditions and will be funded through the company’s cash reserves and ongoing operational cash flow. Adtalem retains the flexibility to adjust or discontinue purchases at any time.
Adtalem is also set to discuss its financial performance in an upcoming conference call on May 8, 2025, signaling its dedication to transparency and communication with stakeholders. The company continues to innovate educational pathways, serving over 90,000 students while maintaining a strong alumni network.
MWN-AI** Analysis
Adtalem Global Education Inc. (NYSE: ATGE) has recently announced a new share repurchase program amounting to $150 million, following the successful completion of a $300 million buyback initiative. This strategic move signals the company’s confidence in its financial health and aligns with its “Growth with Purpose” strategy, emphasizing disciplined capital allocation and robust cash generation.
Investors should interpret this announcement as a positive indicator for Adtalem's future. The execution of share buybacks not only signifies management's belief in the intrinsic value of the company, but also aims to enhance shareholder value by reducing the number of shares outstanding. Since early 2022, Adtalem has returned a notable $763 million to its shareholders while reducing its shares outstanding by 28% at an average buyback price of approximately $49. These metrics reflect a strong capital position and a proactive approach to increasing earnings per share.
Analysts and investors looking at Adtalem’s stock should also consider the current market conditions, as management has highlighted recent market dislocations as an opportunity to acquire shares at attractive valuations. With approximately 36 million shares outstanding and a disciplined, dynamic capital allocation approach, any buybacks under the newly authorized program will be made judiciously based on market evaluations.
Moreover, investors should keep an eye on the forthcoming third-quarter fiscal results, scheduled for release on May 8, 2025. This call will provide further insight into Adtalem's operational performance, cash flow stability, and growth initiatives. Given the company's commitment to expanding its healthcare education capabilities, monitoring these developments will be crucial for assessing long-term investment viability.
In summary, Adtalem Global Education's share repurchase announcement indicates an alignment between management's confidence in the company's future and an ongoing commitment to return value to shareholders. This backdrop, coupled with strong financial fundamentals, presents a potentially attractive entry point for investors in the education sector, especially those focusing on the healthcare segment.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Completes $300 million January 2024 Board-authorized share repurchase program
Reflects operational excellence through Growth with Purpose strategy, robust cash generation and disciplined capital allocation
Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today announced that its board of directors has authorized a new share repurchase program, which allows Adtalem to repurchase up to $150 million of its common stock through May 2028.
In connection with today’s announcement, Adtalem disclosed that it completed its January 2024 board-authorized $300 million share repurchase program on May 5, 2025, representing a significant return to shareholders. The completed repurchase program had been authorized through January 2027.
“The accelerated completion of our share purchase authorization reflects our unwavering confidence in Adtalem’s strong fundamentals and the enduring value of our Growth with Purpose strategy,” said Steve Beard, chairman and chief executive officer, Adtalem Global Education. “Recent market dislocations have created compelling opportunities to purchase shares at attractive valuations, enhancing shareholder value. Moving forward, we will maintain a disciplined yet dynamic allocation approach, prioritizing investments to expand program capacity across our portfolio to drive accelerated growth through 2027 and beyond. By leveraging robust cash flow, we aim to broaden access to high-demand healthcare education, bring new capacity to market and return excess to shareholders.”
Since February 2022, the company has returned $763 million to shareholders, reducing shares outstanding by 28% at an average share repurchase price of approximately $49. The company has approximately 36 million shares of common stock outstanding as of May 5, 2025.
“Execution against our organic growth strategy continues to yield healthy financial returns. Our cash generation has strengthened our balance sheet, affording us the ability to capture opportunities for high-return capital deployment,” said Bob Phelan, senior vice president and chief financial officer, Adtalem Global Education.
Under today’s new share repurchase authorization, the timing and amount of any repurchases will be determined by management based on evaluation of market conditions and other factors. These repurchases may be made through open market purchases, accelerated share repurchases, privately negotiated transactions or otherwise. Any purchases will be at such times and in amounts as the company has approved in accordance with applicable rules and regulations. The repurchases will be funded through available cash balances and ongoing business operating cash generation, and may be suspended or discontinued at any time.
Third Quarter Fiscal Year 2025 Conference Call and Webcast Information
Adtalem will hold a conference call to discuss its third quarter fiscal year 2025 results on Thursday, May 8, 2025, after financial markets close at 4:00 p.m. CT (5:00 p.m. ET).
The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating “Adtalem earnings call” or by using conference ID: 13752889. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com .
Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13752889, or visit the Adtalem investor relations website.
About Adtalem Global Education
Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a practice-ready workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn , Instagram and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506293526/en/
Investor Contact
Jay Spitzer
Investor.Relations@Adtalem.com
+1 312-906-6600
Media Contact
Britt Mitchell
AdtalemMedia@Adtalem.com
+1 872-270-0301
FAQ**
How does the new $150 million share repurchase program authorized by Adtalem Global Education Inc. (NYSE: ATGE) align with its Growth with Purpose strategy and overall financial health?
What factors influenced Adtalem Global Education Inc. ATGE to complete the $300 million share repurchase program earlier than expected, and how does this reflect market conditions?
Given that Adtalem Global Education Inc. ATGE has returned $763 million to shareholders since February 2022, what are the company's plans for further capital allocation to support future growth?
How will the latest share repurchase initiatives impact Adtalem Global Education Inc. ATGE's share price and overall market perception moving forward?
**MWN-AI FAQ is based on asking OpenAI questions about Adtalem Global Education Inc. (NYSE: ATGE).
NASDAQ: ATGE
ATGE Trading
1.87% G/L:
$99.055 Last:
225,507 Volume:
$96 Open:
